FR2978918B1 - PH7 INJECTABLE SOLUTION COMPRISING AT LEAST ONE BASAL INSULIN WITH AN IP BETWEEN 5.8 AND 8.5 - Google Patents

PH7 INJECTABLE SOLUTION COMPRISING AT LEAST ONE BASAL INSULIN WITH AN IP BETWEEN 5.8 AND 8.5

Info

Publication number: FR2978918B1
Authority: FR; France
Prior art keywords: injectable solution; basal insulin; basal; insulin; injectable
Prior art date: 2011-08-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR1157291A

Other languages

French (fr)

Other versions

FR2978918A1 (en

Inventor

Gerard Soula

Olivier Soula

Jeff Tonnar

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Adocia SAS

Original Assignee

Adocia SAS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-08-10

Filing date

2011-08-10

Publication date

2013-12-27

2011-08-10 Priority to FR1157291A priority Critical patent/FR2978918B1/en

2011-08-10 Application filed by Adocia SAS filed Critical Adocia SAS

2012-08-09 Priority to AU2012293463A priority patent/AU2012293463B2/en

2012-08-09 Priority to CA2843586A priority patent/CA2843586A1/en

2012-08-09 Priority to KR1020147005655A priority patent/KR101810055B1/en

2012-08-09 Priority to PCT/FR2012/051880 priority patent/WO2013021143A1/en

2012-08-09 Priority to EP12758562.8A priority patent/EP2741765B9/en

2012-08-09 Priority to JP2014524435A priority patent/JP5950477B2/en

2012-08-09 Priority to MX2014001190A priority patent/MX2014001190A/en

2012-08-09 Priority to US13/571,026 priority patent/US9089476B2/en

2012-08-09 Priority to RU2014108829/15A priority patent/RU2578460C2/en

2012-08-09 Priority to EP16162474.7A priority patent/EP3053590A1/en

2012-08-09 Priority to CN201280038926.9A priority patent/CN103889442B/en

2012-08-09 Priority to DK12758562.8T priority patent/DK2741765T3/en

2012-08-09 Priority to BR112014002986A priority patent/BR112014002986A2/en

2013-02-15 Publication of FR2978918A1 publication Critical patent/FR2978918A1/en

2013-12-27 Application granted granted Critical

2013-12-27 Publication of FR2978918B1 publication Critical patent/FR2978918B1/en

2014-01-23 Priority to IL230611A priority patent/IL230611A/en

2014-01-31 Priority to ZA2014/00773A priority patent/ZA201400773B/en

2015-05-26 Priority to US14/721,889 priority patent/US20170182131A9/en

2018-07-02 Priority to US16/025,832 priority patent/US20180311316A1/en

Status Expired - Fee Related legal-status Critical Current

2031-08-10 Anticipated expiration legal-status Critical

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
102000004877 Insulin Human genes 0.000 title 1
108090001061 Insulin Proteins 0.000 title 1
229940102223 injectable solution Drugs 0.000 title 1
229940125396 insulin Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Diabetes (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Inorganic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

FR1157291A 2011-08-10 2011-08-10 PH7 INJECTABLE SOLUTION COMPRISING AT LEAST ONE BASAL INSULIN WITH AN IP BETWEEN 5.8 AND 8.5 Expired - Fee Related FR2978918B1 (en)

Priority Applications (18)

Application Number	Priority Date	Filing Date	Title
FR1157291A FR2978918B1 (en)	2011-08-10	2011-08-10	PH7 INJECTABLE SOLUTION COMPRISING AT LEAST ONE BASAL INSULIN WITH AN IP BETWEEN 5.8 AND 8.5
CN201280038926.9A CN103889442B (en)	2011-08-10	2012-08-09	Injectable solution of at least one basal insulin
KR1020147005655A KR101810055B1 (en)	2011-08-10	2012-08-09	Injectable solution of at least one type of basal insulin
PCT/FR2012/051880 WO2013021143A1 (en)	2011-08-10	2012-08-09	Injectable solution of at least one type of basal insulin
EP12758562.8A EP2741765B9 (en)	2011-08-10	2012-08-09	Injectable solution of at least one type of basal insulin
JP2014524435A JP5950477B2 (en)	2011-08-10	2012-08-09	Injection solution of at least one basal insulin
MX2014001190A MX2014001190A (en)	2011-08-10	2012-08-09	Injectable solution of at least one type of basal insulin.
US13/571,026 US9089476B2 (en)	2011-08-10	2012-08-09	Injectable solution at pH 7 comprising at least one basal insulin whose PI is between 5.8 and 8.5
RU2014108829/15A RU2578460C2 (en)	2011-08-10	2012-08-09	Basal insulin solution for injections
BR112014002986A BR112014002986A2 (en)	2011-08-10	2012-08-09	composition in the form of a solution for injection, and single dose formulation
AU2012293463A AU2012293463B2 (en)	2011-08-10	2012-08-09	Injectable solution of at least one type of basal insulin
CA2843586A CA2843586A1 (en)	2011-08-10	2012-08-09	Injectable solution of at least one type of basal insulin
EP16162474.7A EP3053590A1 (en)	2011-08-10	2012-08-09	Injectable solution of at least one type of basal insulin
DK12758562.8T DK2741765T3 (en)	2011-08-10	2012-08-09	Injectable solution of at least one type of basal insulin
IL230611A IL230611A (en)	2011-08-10	2014-01-23	Injectable solution of at least one type of basal insulin
ZA2014/00773A ZA201400773B (en)	2011-08-10	2014-01-31	Injectable solution of at least one type of basal insulin
US14/721,889 US20170182131A9 (en)	2011-08-10	2015-05-26	Injectable solution at ph 7 comprising at least one basal insulin whose pi is between 5.8 and 8.5
US16/025,832 US20180311316A1 (en)	2011-08-10	2018-07-02	Injectable solution at ph 7 comprising at least one basal insulin whose pi is between 5.8 and 8.5

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR1157291A FR2978918B1 (en)	2011-08-10	2011-08-10	PH7 INJECTABLE SOLUTION COMPRISING AT LEAST ONE BASAL INSULIN WITH AN IP BETWEEN 5.8 AND 8.5

Publications (2)

Publication Number	Publication Date
FR2978918A1 FR2978918A1 (en)	2013-02-15
FR2978918B1 true FR2978918B1 (en)	2013-12-27

Family

ID=45463750

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR1157291A Expired - Fee Related FR2978918B1 (en)	2011-08-10	2011-08-10	PH7 INJECTABLE SOLUTION COMPRISING AT LEAST ONE BASAL INSULIN WITH AN IP BETWEEN 5.8 AND 8.5

Country Status (1)

Country	Link
FR (1)	FR2978918B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2016001862A1 (en) *	2014-07-04	2016-01-07	Wockhardt Limited	Extended release formulations of insulins
US20210187078A1 (en) *	2016-02-25	2021-06-24	Wockhardt Limited	Pharmaceutical composition of insulin glargine and amino acids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2009532552A (en) *	2006-04-07	2009-09-10	アドシア	Bifunctionalized polysaccharide
MX2008013165A (en) *	2006-04-12	2009-01-29	Biodel Inc	Rapid acting and long acting insulin combination formulations.
FR2940802A1 (en) *	2008-10-10	2010-07-09	Adocia	COMPLEXITY BETWEEN HUMAN INSULIN AND AN AMPHIPHILIC POLYMER AND USE OF THIS COMPLEX FOR PREPARING RAPID HUMAN INSULIN FORMULATION
FR2943538B1 (en) *	2009-03-27	2011-05-20	Adocia	QUICK ACTION FORMULATION OF RECOMBINANT HUMAN INSULIN
FR2958646B1 (en) *	2010-04-07	2012-05-18	Adocia	POLYSACCHARIDES COMPRISING FUNCTIONAL CARBOXYL GROUPS SUBSTITUTED WITH A HYDROPHOBIC ACID DERIVATIVE.
WO2011098962A2 (en) *	2010-02-09	2011-08-18	Adocia	Anionic polysaccharides functionalised by at least two hydrophobic groups supported by an at least trivalent spacer

2011
- 2011-08-10 FR FR1157291A patent/FR2978918B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
FR2978918A1 (en)	2013-02-15

Publication	Publication Date	Title
FR2985428B1 (en)	2016-05-27	PH 7 INJECTABLE SOLUTION COMPRISING AT LEAST ONE BASIC INSULIN WITH A PI BETWEEN 5.8 AND 8.5 AND A SUBSTITUTED POLYAMINOACIDE
FR2985429B1 (en)	2016-07-29	PH 7 INJECTABLE SOLUTION COMPRISING AT LEAST ONE BASIC INSULIN WITH A PI BETWEEN 5.8 AND 8.5 AND A SUBSTITUTED POLYAMINOACID OBTAINED BY A CONTROLLED POLYMERIZATION PROCESS
EP2668586A4 (en)	2014-07-02	CUSTOMER SUPPLY PROVIDED WITH AN INTEGRATED IMAGE BASED ON WINDOWS
IT1398142B1 (en)	2013-02-14	SINGLE SYSTEM WITH COMPRESSOR AND INTEGRATED PUMP AND METHOD.
IT1399905B1 (en)	2013-05-09	LAMINAR TEXTILE STRUCTURE, PARTICULARLY SUITABLE FOR ACOUSTIC COMPONENTS.
EP2663609A4 (en)	2014-06-11	COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC ELECTROLUMINESCENT DIODE COMPRISING THE SAME, AND DISPLAY COMPRISING THE ORGANIC ELECTROLUMINESCENT DIODE
HRP20170209T1 (en)	2017-04-07	LIXISENATIDE AS ADDITIONAL THERAPY WITH BASAL INSULIN IN TYPE 2 DIABETES
MY166565A (en)	2018-07-16	Device for cleaning an encapsulating device for electronic components
FR2975879B1 (en)	2013-06-28	TABLE COMPRISING AT LEAST ONE RETURNABLE FOOT
EP2786410A4 (en)	2015-08-05	QUANTUM WELL DEVICE WITH SIDE ELECTRODES
EP3030891A4 (en)	2017-05-10	Swcnt biosensor for detecting glucose, lactate, and urea
FR3001607B1 (en)	2015-02-20	MONOGRAINE SEMORER WITH AT LEAST ONE PERFECTED ELEMENT
WO2013019646A3 (en)	2013-04-18	Electrical leads for a feedthrough
BR112015026191A2 (en)	2017-07-25	reinforcement bar, flow duct assembly, and method for mounting a vibratory flow meter.
FR3002293B1 (en)	2015-04-10	IMPROVED PRECOMPRESSION PUMP.
EP2725633A4 (en)	2015-07-15	POLYMER FOR USE IN ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE POLYMER
ITRM20100623A1 (en)	2011-08-13	TRANSVERSAL OSCILLATING ARM WITH BENCH PIN AND PROCEDURE FOR MANUFACTURING A TRANSVERSAL OSCILLATING ARM.
WO2013079675A3 (en)	2013-08-22	Device for positioning and securing a display element and display device
FR2978918B1 (en)	2013-12-27	PH7 INJECTABLE SOLUTION COMPRISING AT LEAST ONE BASAL INSULIN WITH AN IP BETWEEN 5.8 AND 8.5
JP2015521279A5 (en)	2016-06-02
BR112014007758A2 (en)	2017-04-25	ortho-substituted phenylisoxazoline-based compound with 2,6-difluorobenzyloxymethyl, method and use thereof
EP2815199A4 (en)	2015-10-07	COUNTERWEIGHT CONTAINER FOR USE IN A NON-BACKWARD, NON-RECOVERED WEAPON COMPRISING SUCH A COUNTERWEIGHT CONTAINER
EP2877200A4 (en)	2016-03-09	INSULIN ANALOGUES MODIFIED BY AN OXYGEN-RELATED CARBOHYDRATE
MX2014003195A (en)	2015-04-29	Access panels.
DE112013004372A5 (en)	2015-05-13	Connecting device between two drive components

Legal Events

Date	Code	Title	Description
2016-08-23	PLFP	Fee payment	Year of fee payment: 6
2018-05-25	ST	Notification of lapse	Effective date: 20180430